View Item 

Show simple item record

Circulatory Assist Devices 2000: An Update

dc.contributor.authorDyke, David B. S.en_US
dc.contributor.authorPagani, Francis D.en_US
dc.contributor.authorAaronson, Keith D.en_US
dc.date.accessioned2010-06-01T18:12:48Z
dc.date.available2010-06-01T18:12:48Z
dc.date.issued2000-09en_US
dc.identifier.citationDyke, David B.S . ; Pagani, Francis D . ; Aaronson, Keith D . (2000). "Circulatory Assist Devices 2000: An Update." Congestive Heart Failure 6(5): 259-271. <http://hdl.handle.net/2027.42/71424>en_US
dc.identifier.issn1527-5299en_US
dc.identifier.issn1751-7133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71424
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12189287&dopt=citationen_US
dc.format.extent1238339 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherCHF, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.rights2000 by CHF, Inc.en_US
dc.titleCirculatory Assist Devices 2000: An Updateen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherFrom the Division of Cardiologyen_US
dc.contributor.affiliationotherthe Section of Cardiac Surgery,en_US
dc.identifier.pmid12189287en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71424/1/j.1527-5299.2000.80165.x.pdf
dc.identifier.doi10.1111/j.1527-5299.2000.80165.xen_US
dc.identifier.sourceCongestive Heart Failureen_US
dc.identifier.citedreferenceDale HH, Schuster EHJ. A double perfusion pump. J Physiol. 1928; 64: 356 – 364.en_US
dc.identifier.citedreferenceDeBakey ME. A simple continuous flow blood transfusion instrument. New Orleans Med Surg J. 1934; 87: 386 – 389.en_US
dc.identifier.citedreferenceDeVries WC, Joyce LD. The artificial heart. Clin Symposia. 35 ( 6 ): 1 – 32.en_US
dc.identifier.citedreferenceGibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. 1954; 37: 171 – 180.en_US
dc.identifier.citedreferenceAkutsu T, Kolff WJ. Permanent substitutes for valves and hearts. Trans Am Soc Artif Intern Organs. 1958; 4: 230 – 235.en_US
dc.identifier.citedreferenceKantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968; 203 ( 2 ): 113 – 118.en_US
dc.identifier.citedreferenceCooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969; 24 ( 5 ): 723 – 730.en_US
dc.identifier.citedreferenceDeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med. 1984; 310 ( 5 ): 273 – 278.en_US
dc.identifier.citedreferenceGoldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998; 339 ( 21 ): 1522 – 1533.en_US
dc.identifier.citedreferenceRose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: Rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg. 1999; 67 ( 3 ): 723 – 730.en_US
dc.identifier.citedreferenceReinhartz O, Farrar DJ, Hershon JH, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg. 1998; 116 ( 4 ): 633 – 640.en_US
dc.identifier.citedreferencePagani FD, Lynch W, Swaniker F, et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation. 1999; 100 ( suppl 19 ): II206 – II210.en_US
dc.identifier.citedreferenceMcCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg. 1998; 115 ( 4 ): 904 – 912.en_US
dc.identifier.citedreferenceFrazier OH, Macris MP, Myers TJ, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994; 57 ( 6 ): 1416 – 1422.en_US
dc.identifier.citedreferenceOz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995; 92 ( suppl 9 ): II169 – II173.en_US
dc.identifier.citedreferenceMehta SM, Aufiero TX, Pae WE Jr, et al. Mechanical ventricular assistance: An economical and effective means of treating end-stage heart disease. Ann Thorac Surg. 1995; 60 ( 2 ): 284 – 290.en_US
dc.identifier.citedreferenceMorales DL, Catanese KA, Helman DN, et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: Safe, economical, necessary. J Thorac Cardiovasc Surg. 2000; 119 ( 2 ): 251 – 259.en_US
dc.identifier.citedreferenceGelijns AC, Richards AF, Williams DL, et al. Evolving costs of long-term left ventricular assist device implantation. Ann Thorac Surg. 1997; 64 ( 5 ): 1312 – 1319.en_US
dc.identifier.citedreferenceMoscucci M, Lynch W, Swaniker F, et al. Atrial balloon septostomy in the management and prevention of pulmonary hemorrhage in patients requiring extracorporeal life support. Extracorporeal Life Support Organization 9th annual meeting, Ann Arbor, MI; 1999.en_US
dc.identifier.citedreferencePoirier VL. Worldwide experience with the TCI HeartMate system: Issues and future perspective. Thorac Cardiovasc Surg. 1999; 47 ( suppl 2 ): 316 – 320.en_US
dc.identifier.citedreferenceRose EA, Levin HR, Oz MC, et al. Artificial circulatory support with textured interior surfaces: A counterintuitive approach to minimizing thromboembolism. Circulation. 1994; 90 ( 5 pt II ): II87 – II91.en_US
dc.identifier.citedreferenceArabia FA, Smith RG, Rose DS, et al. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996; 42 ( 5 ): M542 – M546.en_US
dc.identifier.citedreferenceArgenziano M, Choudhri AF, Moazami N, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 1998; 65 ( 2 ): 340 – 345.en_US
dc.identifier.citedreferenceHare JM, Shernan SK, Body SC, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance ( published erratum. Circulation. 1997;96(3):1065 ). Circulation. 1997; 95 ( 9 ): 2250 – 2253.en_US
dc.identifier.citedreferenceLoh E, Stamler JS, Hare JM, et al. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994; 90 ( 6 ): 2780 – 2785.en_US
dc.identifier.citedreferenceOz MC, Rose EA, Slater J, et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994; 24 ( 7 ): 1688 – 1691.en_US
dc.identifier.citedreferenceMyers TJ, McGee MG, Zeluff BJ, et al. Frequency and significance of infections in patients receiving prolonged LVAD support. ASAIO Trans. 1991; 37: M283 – M285.en_US
dc.identifier.citedreferenceFrazier OH, Duncan JM, Radovancevic B, et al. Successful bridge to heart transplantation with a new left ventricular assist device. J Heart Lung Transplant. 1992; 11: 530 – 537.en_US
dc.identifier.citedreferenceKormos RL, Murali S, Dew A, et al. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994; 57: 51 – 58.en_US
dc.identifier.citedreferenceArgenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997; 16 ( 8 ): 822 – 831.en_US
dc.identifier.citedreferenceDajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. 1997; 96 ( 1 ): 358 – 366.en_US
dc.identifier.citedreferenceLavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panelreactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant. 1991; 10 ( 6 ): 921 – 929.en_US
dc.identifier.citedreferenceMoazami N, Itescu S, Williams MR, et al. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant. 1998; 17 ( 9 ): 876 – 880.en_US
dc.identifier.citedreferenceStringham JC, Bull DA, Fuller TC, et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant. 1999; 18 ( 2 ): 160 – 165.en_US
dc.identifier.citedreferenceTsau PH, Arabia FA, Toporoff B, et al. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: Risk factors and treatment. ASAIO J. 1998; 44 ( 5 ): M634 – M637.en_US
dc.identifier.citedreferencePagani FD, Dyke DB, Wright S, et al. Development of anti-major histocompatibility complex class I or II antibodies following LVAD implant: Effects on subsequent allograft rejection and survival (abstract). J Heart Lung Transplant. 2000; 19 ( 1 ): 57.en_US
dc.identifier.citedreferenceIcenogle TB, Smith RG, Cleavinger M, et al. Thromboembolic complications of the Symbion AVAD System. Artificial Organs. 1989; 13 ( 6 ): 532 – 538.en_US
dc.identifier.citedreferenceLevinson MM, Smith RG, Cork RC, et al. Thromboembolic complications of the Jarvik-7 total artificial heart: Case report. Artificial Organs. 1986; 10 ( 3 ): 236 – 244.en_US
dc.identifier.citedreferenceWagner WR, Johnson PC, Kormos RL, et al. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation. 1993; 88 ( 5 pt 1 ): 2023 – 2029.en_US
dc.identifier.citedreferenceFarrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg. 1993; 55 ( 1 ): 276 – 282.en_US
dc.identifier.citedreferenceKormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: Rehabilitation, low morbidity, and superior survival. Ann Thorac Surg. 1994; 57 ( 1 ): 51 – 57.en_US
dc.identifier.citedreferenceMurali S. Mechanical circulatory support with the Novacor LVAS: World-wide clinical results. Thorac Cardiovasc Surg. 1999; 47 ( suppl 2 ): 321 – 325.en_US
dc.identifier.citedreferenceRamasamy N, Wheeldon D, Jansen P, et al. Reduction of embolic complications in left ventricular assist systems (LVAS) recipients: Impact of inflow conduit design (abstract). J Heart Lung Transplant. 2000; 19 ( 1 ): 58.en_US
dc.identifier.citedreferenceSzefner J. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitie Hospital with patients on total artificial heart. Int J Artificial Organs. 1995; 18 ( 10 ): 633 – 648.en_US
dc.identifier.citedreferenceJohnson KE, Prieto M, Joyce LD, et al. Summary of the clinical use of the Symbion total artificial heart: A registry report. J Heart Lung Transplant. 1992; 11 ( 1pt1 ): 103 – 116.en_US
dc.identifier.citedreferenceCopeland JG III, Arabia FA, Banchy ME, et al. The Cardio-West total artificial heart bridge to transplantation: 1993 to 1996 national trial. Ann Thorac Surg. 1998; 66 ( 5 ): 1662 – 1669.en_US
dc.identifier.citedreference47 HeartMate LVAS Clinical Results, January 2000. Data on file with Thermo Cardiosystems Inc.en_US
dc.identifier.citedreferenceCopeland JG, Arabia FA, Smith RG, et al. Arizona experience with CardioWest total artificial heart bridge to transplantation. Ann Thorac Surg. 1999; 68 ( 2 ): 756 – 760.en_US
dc.identifier.citedreferenceKormos RL, Ramasamy N, Sit S et al. for the U.S. Multicenter Investigators. Bridge-to-transplant (BTT) experience with the Novacor Left Ventricular Assist System (LVAS): Results of a multicenter study. J Heart Lung Transplant. 1999; 18 ( 1 ): 63.en_US
dc.identifier.citedreference50 Thoratec VAD System Clinical Monograph. January, 2000.en_US
dc.identifier.citedreferenceArabia FA, Smith RG, Rose DS, et al. Success rates of longterm circulatory assist devices used currently for bridge to transplantation. ASAIO J. 1996; 42 ( 5 ): M542 – M546.en_US
dc.identifier.citedreferenceFrazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996; 62 ( 3 ): 675 – 681.en_US
dc.identifier.citedreferenceDipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with endstage heart failure. Circulation. 1998; 97 ( 23 ): 2316 – 2322.en_US
dc.identifier.citedreferenceDelgado R III, Radovancevic B, Massin EK, et al. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 1998; 44 ( 4 ): 299 – 302.en_US
dc.identifier.citedreferenceMuller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997; 96 ( 2 ): 542 – 549.en_US
dc.identifier.citedreferenceMancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998; 98 ( 22 ): 2383 – 2389.en_US
dc.identifier.citedreference57 Abiomed Annual Report, 1998. Danvers, MA.en_US
dc.identifier.citedreferenceWieselthaler GM, Schima H, Hiesmayr M, et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 2000; 101 ( 4 ): 356 – 359.en_US
dc.identifier.citedreferenceWestaby S, Katsumata T, Houel R, et al. Jarvik 2000 heart: Potential for bridge to myocyte recovery. Circulation. 1998; 98 ( 15 ): 1568 – 1574.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1527-5299.2000.80165.x.pdf
Size:
1.180MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.